Bristol-Myers Squibb publishes application for a process to prepare tert-butyl (2-azabicyclo[2.2.1]heptan-4-yl)carbamate.
The filing
Bristol-Myers Squibb published an application on November 12, 2026, for a process to prepare tert-butyl (2-azabicyclo[2.2.1]heptan-4-yl)carbamate and related compounds. The application is available at US20260356805A1 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.